Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Individual Patient Study of Cytomegalovirus (CMV)-Specific Donor-derived T Lymphocytes (DTL) for the Treatment of Recalcitrant CMV Infection in a Patient With Primary Immunodeficiency

NCT07015801 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT07015801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07015801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Individual Patient Study of Cytomegalovirus (CMV)-Specific Donor-derived T Lymphocytes (DTL) for the Treatment of Recalcitrant CMV Infection in a Patient With Primary Immunodeficiency
Lead sponsor
University of Calgary
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 15, 2025
Completion date
April 30, 2040
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cytomegalovirus pneumonia, cytomegalovirus viremia, t-lymphocyte immunodeficiency